Middlesex, NJ, United States of America

Stephen Overholt

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 50(Granted Patents)


Location History:

  • Middlesex, NJ (US) (2013 - 2015)
  • St. Louis, MO (US) (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Overholt

Introduction

Stephen Overholt is a notable inventor based in Middlesex, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. With a total of 3 patents to his name, Overholt's work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents focuses on methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans. This patent outlines innovative techniques for preparing protected granules that contain morphinans. The resulting solid dosage form pharmaceutical compositions are produced using these morphinan-protected granules, showcasing Overholt's commitment to advancing pharmaceutical technology.

Career Highlights

Stephen Overholt is currently associated with Mallinckrodt, Inc., where he continues to apply his expertise in pharmaceutical innovations. His work has been instrumental in enhancing the quality and stability of pharmaceutical products, which is crucial for patient safety and efficacy.

Collaborations

Overholt has collaborated with talented individuals such as Jae Han Park and Tiffani Eisenhauer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stephen Overholt's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective pharmaceutical compositions, ensuring better health outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…